Live updates: House passes massive tax and spending bill in win for Johnson, Trump
Trump is expected to sign the bill on the Fourth of July, his deadline for getting the package to his desk.
But final passage didn't come easy. GOP leaders held open procedural votes for hours as they sought to sway holdouts, Trump got directly involved, and House Minority Leader Hakeem Jeffries (D-N.Y.) delivered an 8 hour-and-44 minute floor speech railing against the measure. Republican Reps. Thomas Massie (Ky.) and Brian Fitzpatrick (Pa.) voted against the bill in the end.
Still, passing the bill marks a major victory for both Trump and Speaker Mike Johnson (R-La.).
Elsewhere, Trump will join first lady Melania Trump in meeting Thursday with former Israeli hostage Edan Alexander. He'll then fly to Iowa, where he'll kick off the nation's 250th birthday celebration with a speech at the state fairgrounds.
Worth a read:
Supreme Court takes up transgender athlete bans at schools
Trump to speak with Putin on Thursday
Trump plays hardball as tariff deadline looms
Follow along with live updates below.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Investing $1,000 Into This Top Dividend Stock in July Could Grow to Over $4,250 by 2035
Brookfield Renewable has delivered a 15.6% average annual total return since 2001. The company expects to grow its 4.5%-yielding dividend by 5% to 9% annually. It anticipates delivering more than 10% annual FFO per share growth for the next decade. 10 stocks we like better than Brookfield Renewable › Brookfield Renewable (NYSE: BEPC)(NYSE: BEP) has been a wealth-creating machine over the years. The leading global renewable energy producer has grown its dividend at a 6% compound annual rate since 2001. That has helped power a 15.6% average annual total return for its investors. While that past performance doesn't guarantee its future returns will be as strong, the company's current outlook suggests the next 10 years could be just as good, if not better. If Brookfield can deliver similar returns over that period, it could grow a $1,000 investment made this July into more than $4,250 by the middle of 2035. Brookfield Renewable currently pays a dividend yielding around 4.5%. That's more than three times higher than the S&P 500, which yields less than 1.5%. Brookfield's high-yielding dividend provides investors with a very strong base return. That payout is on a very sustainable foundation. Brookfield sells 90% of its electricity under long-term, fixed-rate power purchase agreements (PPAs) with an average remaining term of 14 years. Most of those PPAs link rates to inflation, accounting for 70% of Brookfield's revenue and allowing the company to produce predictable and steadily rising cash flow. Brookfield estimates that inflation-linked rate increases will boost its funds from operations (FFO) by 2% to 3% per share each year. The market price for renewable energy is rising faster than inflation because of robust demand, and Brookfield expects to lock in even higher power prices as legacy PPAs expire. Recontracting and other margin enhancement activities should add another 2% to 4% to its FFO per share each year. The stable and growing cash flow from Brookfield's existing portfolio puts its high-yielding dividend on a solid foundation. The company also has a strong investment-grade balance sheet, further fortifying its payout. Brookfield Renewable has two other growth drivers: Development projects and acquisitions. The company has 74 gigawatts (GW) of renewable energy projects in its advanced-stage pipeline. That's almost double its current operating capacity of nearly 45 GW. It expects to commission 8 GW of projects this year as it ramps up to its target of 10 GW annually by 2027. Brookfield estimates that development projects will add 4% to 6% to its FFO per share each year. The company is steadily signing PPAs to support its development pipeline. It inked a massive 10.5 GW deal with Microsoft last year for projects it expects to develop in the 2026-to-2030 timeframe. Brookfield believes it could eventually provide the technology company with even more power in the future, given the immense demand for electricity needed to power AI data centers. In addition, Brookfield expects to continue making accretive acquisitions largely funded by recycling capital. The company recently closed its acquisition of French renewable energy developer Neoen, which enhanced its development pipeline in several fast-growing markets. It also recently agreed to buy National Grid's U.S. onshore renewable-energy platform. That deal will add 3.9 GW of operating and under construction assets, a 1 GW construction-ready portfolio, and more than 30 GW of development projects. It's funding these new investments by selling several assets at strong valuations. Brookfield believes that its capital recycling strategy will further accelerate its growth rate. Brookfield estimates that this quartet of catalysts will grow its FFO per share at more than a 10% annual rate for the foreseeable future. That growth is highly visible and secured through the end of the decade, and increasingly visible and secured in 2030 and beyond. Brookfield Renewable's high-yielding dividend provides a solid and growing base return. It's targeting 5% to 9% annual dividend increases. On top of that, the company expects to grow its FFO per share at more than a 10% annual rate for at least the next decade. It has delivered 11% compound annual growth over the past 10 years. Add the dividend yield to the company's growth rate, and Brookfield could deliver total returns above 15% annually. That strong probability of earning a high total return makes Brookfield Renewable a great stock to invest $1,000 into this July. Before you buy stock in Brookfield Renewable, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Brookfield Renewable wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor's total average return is 1,045% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Matt DiLallo has positions in Brookfield Renewable and Brookfield Renewable Partners. The Motley Fool has positions in and recommends Microsoft. The Motley Fool recommends Brookfield Renewable, Brookfield Renewable Partners, and National Grid Plc and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Investing $1,000 Into This Top Dividend Stock in July Could Grow to Over $4,250 by 2035 was originally published by The Motley Fool
Yahoo
32 minutes ago
- Yahoo
Trump Proposes UFC Event in Wild Location
Trump Proposes UFC Event in Wild Location originally appeared on Athlon Sports. President Donald Trump's relationship with the UFC is well-documented. He has attended multiple events, and fighters like Conor McGregor have visited him at the White House, reinforcing the alliance between the MMA promotion and his political brand. The UFC's massive popularity, especially among younger male demographics, makes it a centerpiece for Trump and his supporters, who include the UFC's CEO and President, Dana White. Advertisement Now, Trump has floated a bold and unconventional idea to celebrate America's upcoming 250th anniversary: a UFC championship fight on the White House grounds. Donald Trump and Dana WhiteEd Mulholland-GettyImages During a speech at the Iowa State Fairgrounds, Trump revealed his desire for a large-scale event featuring a UFC fight with up to 25,000 spectators as part of the "America250" festivities. 'Does anybody watch UFC? The great Dana White? We're going to have a UFC fight. We're going to have a UFC fight, think of this, on the grounds of the White House. We have a lot of land there,' Trump said. While the announcement energized Trump's supporters, the feasibility and appropriateness of hosting a violent combat sport on White House property were clearly not in the president's consideration. The White House has never before been used as a venue for a pay-per-view sporting event, let alone a sport with a fan base as rowdy as MMA. Advertisement Overlooked in his proclamation were the logistical hurdles, including Secret Service approvals and crowd control, that could make the plan more aspirational than practical. The UFC's involvement adds another layer of controversy. While the organization has grown into a mainstream sports powerhouse, it has also faced criticism over fighter pay, benefits, and overall dwindling quality. As of now, the proposal lacks concrete details, and the idea is likely nothing more than mere political theater. Given Trump's history of controversy, however, the possibility cannot be entirely ruled out. Related: The UFC Could Be On The Verge Of A Huge Partnership Related: Dana White & Mark Zuckerberg Announce UFC-Meta Partnership: Enhanced Fan Experience, But at What Cost to Fighters? This story was originally reported by Athlon Sports on Jul 4, 2025, where it first appeared.
Yahoo
33 minutes ago
- Yahoo
Corcept Therapeutics' Korlym Shows Glucose Control, Weight Reduction in Hypercortisolism, Type 2 Diabetes Patients
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June 24, Corcept Therapeutics announced positive results from the CATALYST trial of Korlym (mifepristone). The data was presented at the American Diabetes Association's 85th Scientific Sessions and also published in Diabetes Care. It showed that Korlym improved glucose control in patients with hypercortisolism (Cushing's syndrome) and difficult-to-control type 2 diabetes. The trial met its primary endpoint, as patients receiving Korlym experienced a 1.47% decrease in HbA1c from baseline, as compared to a 0.15% decrease in the placebo group. Those on a 900mg dose saw a 2.01% HbA1c improvement. Beyond blood sugar, Korlym also led to reductions in body weight (by 5.1 kg) and waist circumference (by 5.1 cm), even as patients reduced or stopped other glucose-lowering medications. A biologist in a lab coat studying a culture of cells to find a cure for metabolic disorders. The CATALYST trial is the largest to date investigating hypercortisolism in difficult-to-control type 2 diabetes. Its initial phase screened 1,057 patients and found that 24% had hypercortisolism, which made them eligible for the treatment phase. Corcept Therapeutics Incorporated (NASDAQ:CORT) discovers and develops medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the US. While we acknowledge the potential of CORT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
